Membrane-Based Water for Injection

Historically, distillation has been the most common technology used to produce Water for Injection (WFI), due to prior process advantages and historical regulatory requirements.  Changes in the European Pharmacopeiano longer require the use of distillation systems to produce WFI. In this webcast, learn about the impact of this regulatory change on water system design and how reverse osmosis and ultrafiltration can be used to produce WFI with significant lifecycle cost advantages.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Control-Alter-Delete: Epigenetic Regulation by Non-Coding RNAs in Neuronal Systems Webinar

news-medical

Listen in as Dr Jeremy Day, of the Department of Neurobiology at the University of Alabama at Birmingham, discusses his work exploring non-coding RNA species regulation of DNA methylation in neuronal system- including a review of some of his lab's latest unpublished data.
Watch Now

What pharmaceutical marketers can do now to stay ahead of the evolving customer journey

Tag

In association with pharmaphorum, Tag discusses what pharmaceutical marketers can to do stay ahead of the evolving customer journey.
Watch Now

Coming Down the DSCSA Stretch – Authorized Trading Partners, and What You Need to Know

The Drug Supply Chain Security Act (DSCSA) has its final deadline approaching in November 2023. To confirm that only trusted entities are involved in the exchange of prescription drugs, one of the lesser thought-about elements mandates that the required data exchange through the supply chain is only done with authorized and registered trading partners.
Watch Now

How to get speed and depth in your Host Cell Protein (HCP) analysis

Technology Networks

In the rapidly expanding arena of biotherapeutic analysis and bioprocess development, the analysis of host cell proteins (HCP) is transitioning to a new phase. HCPs are contaminants in biotherapeutic drug preparations, often at low ppm concentration levels, and must be monitored due to stability, efficacy and immunogenicity concerns. Often, these protein impurities will be considered Critical Quality Attributes (CQA) and can contribute to an overall risk assessment for the product.
Watch Now

Spotlight

resources